Monday, October 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 17, 2026

ZenaTech desarrolla un dron interceptor autónomo de bajo costo y de un solo uso para el sistema Counter-UAS de ZenaDrone para uso en defensa de EE. UU., Medio Oriente y Ucrania

View original at globenewswire.com
ZenaTech desarrolla un dron interceptor autónomo de bajo costo y de un solo uso para el sistema Counter-UAS de ZenaDrone para uso en defensa de EE…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The drone threat on modern battlefields is accelerating faster than legacy defense budgets can absorb. The Interceptor P-1 is being developed to give military and security forces an accessible and scalable response by creating an interceptor and anti-drone system for a new world of asymmetric warfare.

    60% confidence
  • The company targets initial prototype completion in the coming months and will provide further updates on product development, regulatory milestones, and engagement and pilots with government and defense agencies as progress continues.

    60% confidence
  • ZenaTech management believes the company is positioning Interceptor P-1 for future acquisition contract opportunities with allied governments, NATO partners, and Gulf Cooperation Council (GCC) defense customers.

    60% confidence
  • The global counter-drone market is growing at more than 25% annually and is projected to exceed $10 billion by 2030, driven by intensifying drone warfare in multiple active theaters and the proliferation of commercially available drones repurposed for battlefield use.

    60% confidence
  • ZenaTech's strategy is to offer defense customers a full spectrum of counter-drone solutions based on persistent maritime patrols with the ZenaDrone 2000 launch station and IQ Glider. Their emerging technologies are also forming a comprehensive, layered counter-UAS ecosystem for land, maritime and coastal environments with the disposable point interception capabilities of the Interceptor P-1.

    60% confidence
  • This is exactly the type of integrated and cost-effective capability that modern defense acquisition demands.

    60% confidence

Data points we hold from this source

ZenaTech, Inc. · market growth rate25 percent
ZenaTech, Inc. · market value10 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com